Search Results - "De Vita, Fernando"
-
1
Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey
Published in PloS one (28-10-2013)“…Bone metastasis represents an increasing clinical problem in advanced gastric cancer (GC) as disease-related survival improves. In literature, few data on the…”
Get full text
Journal Article -
2
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment
Published in ESMO open (2017)“…Please click here to see linked paper BackgroundTo investigate the potential predictors of response to regorafenib, in chemorefractory metastatic colorectal…”
Get full text
Journal Article -
3
Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
Published in Frontiers in pharmacology (20-07-2017)“…In metastatic renal cell carcinoma, complete response to first-line antiangiogenic agents is rare and resistance to therapy often develops. Protocols for…”
Get full text
Journal Article -
4
Emerging VEGF-receptor inhibitors for colorectal cancer
Published in Expert opinion on emerging drugs (01-03-2013)“…Targeted agents have dramatically improved and enriched the therapeutical choices for patients with metastatic colorectal cancer (mCRC). By better…”
Get more information
Journal Article -
5
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
Published in BMC cancer (11-04-2011)“…Mortality is high in patients with esophageal carcinoma as tumors are rarely detected before the disease has progressed to an advanced stage. Here, we sought…”
Get full text
Journal Article -
6
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
Published in European journal of cancer (1990) (01-01-2014)“…Abstract Background The discordance in oestrogen receptor (ER), progesterone receptor (PgR) and human epidermal growth factor receptor 2 (HER2) status between…”
Get full text
Journal Article -
7
Gastric cancer: Translating novels concepts into clinical practice
Published in Cancer treatment reviews (01-09-2019)“…•FLOT is the new perioperative gold standard yet more than 50% of patients with GC develop recurrence and die from their cancer.•Novel biomarkers such as MSI…”
Get full text
Journal Article -
8
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis
Published in Pancreas (01-07-2018)“…Two issues were put forth by clinicians in the management of the advanced stages of rare variants of pancreatic ductal adenocarcinoma and other exocrine…”
Get full text
Journal Article -
9
Corrigendum to “Gastric cancer: Translating novels concepts into clinical practice” [Cancer Treatm. Rev. 79C (2019) 101889]
Published in Cancer treatment reviews (01-12-2019)Get full text
Journal Article -
10
Final results of neutrophil-to-lymphocyte ratio (NLR) as a prognostic marker in advanced pancreatic cancer patients treated with Nab-paclitaxel plus Gemcitabine
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
11
The Italian Rare Pancreatic Exocrine Cancer Initiative
Published in Tumori (01-08-2019)“…Introduction: Exocrine pancreatic cancers include common type pancreatic ductal adenocarcinoma and cystic neoplasms, which account for 85% and 10% of cases,…”
Get full text
Journal Article -
12
Whole-exome sequencing in radically resected gastric cancer (GC): Analysis of patients (pts) with poor prognostic factors from the Italian Trial of Adjuvant Chemotherapy Adenocarcinoma (ITACA-S) trial
Published in Journal of clinical oncology (01-02-2017)“…Abstract only 64 Background: At present, the clinical management of resected GC is only based on risk stratification according to the AJCC staging. This…”
Get full text
Journal Article -
13
Increased circulating levels of VEGF-C to predict outcome in resectable gastric cancer patients
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
14
Combination nab-paclitaxel (Nab-P) plus gemcitabine (G) as first-line treatment in advanced pancreatic cancer (APC): Our experience
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
15
Peripherally Inserted Central Catheter Tip Position: A Novel Empirical-Ultrasonographical Index in a Modern Surgical Oncology Department
Published in Annals of surgical oncology (01-02-2014)“…Background The correct positioning of ultrasound-guided, peripherally inserted central catheters (UGPICCs) is essential to avoid multiple complications. We…”
Get full text
Journal Article -
16
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
Published in Annals of oncology (01-08-2007)“…Background: This randomized, multicenter, phase III trial evaluated the efficacy and safety of the combination of epirubicin, leucovorin, 5-fluorouracil and…”
Get full text
Journal Article -
17
A meta-analysis of receptor status discordance between primary breast cancer and metastases
Published in Journal of clinical oncology (20-05-2012)“…Abstract only 546 Background: There is an increasing awareness that biology of breast cancer may evolve over time. The discordance in estrogen (ER),…”
Get full text
Journal Article -
18
Natural history of malignant bone disease in gastric cancer: Final results of a multicenter bone metastasis survey
Published in Journal of clinical oncology (20-05-2013)“…Abstract only 4091 Background: Bone metastasis represents an increasing clinical problem in advanced gastric cancer (GC) as disease-related survival improves…”
Get full text
Journal Article -
19
Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines
Published in Expert opinion on therapeutic targets (01-04-2012)“…Chemotherapy-induced neutropenia, the depth and length of which are correlated to the risk of febrile neutropenia (FN) and neutropenia sepsis, remains a…”
Get more information
Journal Article -
20
KSR1 gene polymorphism in mCRC patients treated with first-line FOLFIRI and bevacizumab
Published in Journal of clinical oncology (20-05-2012)“…Abstract only 3546 Background: Kinase suppressor of Ras (KSR) 1 is a scaffolding protein regulating the Raf/Mek/ERK cascade. Preclinical data showed that KSR1…”
Get full text
Journal Article